Jia-He Zhao

T-cell redirecting therapies in lung cancer - a comprehensive analysis of clinical trials

T cell-redirected therapy is positioned to extend the survival frontier for patients whose lung cancer has escaped existing treatments, and combination strategies pairing T cell-redirected therapies with ICIs, antibody-drug conjugates, and allogeneic or innate immune effectors represent the most promising path toward d...